Chinese NMPA Released the National Medical Products Newsletter

The newly released NMPA newsletter reported some important NMPA announcements including:

• Center for Drug Evaluation of NMPA Announced on Issuing the Administrative Measures for Communication of Drug R&D and Technical Review
• SAMR (State Administration for Market Regulation) Released the Provisions for the Lot Release of Biological Products
• NMPA Announcement on Issues Pertaining to Online Application for Drug Registration Affairs
• NMPA Announcement on Issuing the Provisions for the Change Management of Post-approval Drugs (Interim)
• NMPA Announcement on the Application of ICH Guideline E9 (R1): Estimands and Sensitivity Analysis in Clinical Trials
• NMPA Announcement on Issuing the Catalogue of Medical Devices Exempt from Clinical Trials (Revised Second Batch)